Influence of brain-derived neurotrophic factor and catechol O-methyl transferase polymorphisms on effects of meditation on plasma catecholamines and stress

References

• Alexander N, Osinsky R, Schmitz A, Mueller E, Kuepper Y, Hennig J. 2010. The BDNF Val66Met polymorphism affects HPA-axis reactivity to acute stress. Psychoneuroendocrinology. 35:949–953.
   PubMed Web of Science ®Google Scholar
• Brown J, Cooper-Kuhn CM, Kempermann G, Van Praag H, Winkler J, Gage FH, Kuhn HG. 2003. Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis. Eur J Neurosci. 17:2042–2046.
   PubMed Web of Science ®Google Scholar
• Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, Egan MF, Kleinman JE, Weinberger DR. 2004. Functional analysis of genetic variation in catechol-O-Methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet. 75:807–821.
   PubMed Web of Science ®Google Scholar
• Choi SM, Kang TY, Woo JM. 2006. Development and validation of a modified form of the stress response inventory for workers. J Korean Neuropsychiatr Assoc. 45:541–553.
   Google Scholar
• Cotman CW, Berchtold NC. 2002. Exercise: A behavioral intervention to enhance brain health and plasticity. Trends Neurosci. 25:295–301.
   PubMed Web of Science ®Google Scholar
• Dusek JA, Otu HH, Wohlhueter AL, Bhasin M, Zerbini LF, Joseph MG, Benson H, Libermann TA. 2008. Genomic counter-stress changes induced by the relaxation response. PLoS One. 3:e2576.
   PubMed Web of Science ®Google Scholar
• Glaser R, Kiecolt-Glaser JK. 2005. Stress-induced immune dysfunction: Implications for health. Nat Rev Immunol. 5:243–251.
   PubMed Web of Science ®Google Scholar
• Goggi J, Pullar IA, Carney SL, Bradford HF. 2003. Signalling pathways involved in the short-term potentiation of dopamine release by BDNF. Brain Res. 968:156–161.
   PubMed Web of Science ®Google Scholar
• Infante JR, Torres-Avisbal M, Pinel P, Vallejo JA, Peran F, Gonzalez F, Contreras P, Pacheco C, Roldan A, Latre JM. 2001. Catecholamine levels in practitioners of the transcendental meditation technique. Physiol Behav. 72:141–146.
   PubMed Web of Science ®Google Scholar
• Jain S, Shapiro SL, Swanick S, Roesch SC, Mills PJ, Bell I, Schwartz GE. 2007. A randomized controlled trial of mindfulness meditation versus relaxation training: Effects on distress, positive states of mind, rumination, and distraction. Ann Behav Med. 33:11–21.
   PubMed Web of Science ®Google Scholar
• Jones BM. 2001. Changes in cytokine production in healthy subjects practicing Guolin Qigong: A pilot study. BMC Complement Altern Med. 1:8.
   PubMedGoogle Scholar
• Jung YH, Kang DH, Jang JH, Park HY, Byun MS, Kwon SJ, Jang GE, Lee US, An SC, Kwon JS. 2010. The effects of mind–body training on stress reduction, positive affect, and plasma catecholamines. Neurosci Lett. 479:138–142.
   Google Scholar
• Kim SJ, Cho SJ, Jang HM, Shin J, Park PW, Lee YJ, Cho IH, Choi JE, Lee HJ. 2010. Interaction between brain-derived neurotrophic factor Val66Met polymorphism and recent negative stressor in harm avoidance. Neuropsychobiology. 61:19–26.
   Google Scholar
• Koh KB, Park JK, Kim CH, Cho S. 2001. Development of the stress response inventory and its application in clinical practice. Psychosom Med. 63:668–678.
   PubMed Web of Science ®Google Scholar
• Kolassa IT, Kolassa S, Ertl V, Papassotiropoulos A, De Quervain DJ. 2010. The risk of posttraumatic stress disorder after trauma depends on traumatic load and the catechol-O-methyltransferase Val(158)Met polymorphism. Biol Psychiatry. 67:304–308.
   PubMed Web of Science ®Google Scholar
• Koolhaas JM, Bartolomucci A, Buwalda B, de Boer SF, Flügge G, Korte SM, Meerlo P, Murison R, Olivier B, Palanza P, Richter-Levin G, Sgoifo A, Steimer T, Stiedl O, van Dijk G, Wöhr M, Fuchs E. 2011. Stress revisited: A critical evaluation of the stress concept. Neurosci Biobehav Rev. 35 5: 1291–1301.
   PubMed Web of Science ®Google Scholar
• Lapiz MD, Morilak DA. 2006. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience. 137:1039–1049.
   PubMed Web of Science ®Google Scholar
• Lazar SW, Kerr CE, Wasserman RH, Gray JR, Greve DN, Treadway MT, McGarvey M, Quinn BT, Dusek JA, Benson H, Rauch SL, Moore CI, Fischl B. 2005. Meditation experience is associated with increased cortical thickness. Neuroreport. 16:1893–1897.
   PubMed Web of Science ®Google Scholar
• Lee E, Son H. 2009. Adult hippocampal neurogenesis and related neurotrophic factors. BMB Rep. 42:239–244.
   PubMed Web of Science ®Google Scholar
• Lee J, Duan W, Mattson MP. 2002. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem. 82:1367–1375.
   PubMed Web of Science ®Google Scholar
• Lee SH, Ahn SC, Lee YJ, Choi TK, Yook KH, Suh SY. 2007. Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder. J Psychosom Res. 62:189–195.
   PubMed Web of Science ®Google Scholar
• Miller JJ, Fletcher K, Kabat-Zinn J. 1995. Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. Gen Hosp Psychiatry. 17:192–200.
   PubMed Web of Science ®Google Scholar
• Mravec B. 2011. Role of catecholamine-induced activation of vagal afferent pathways in regulation of sympathoadrenal system activity: Negative feedback loop of stress response. Endocr Regul. 45:37–41.
   PubMedGoogle Scholar
• Newberg AB, Wintering N, Khalsa DS, Roggenkamp H, Waldman MR. 2010. Meditation effects on cognitive function and cerebral blood flow in subjects with memory loss: A preliminary study. J Alzheimers Dis. 20:517–526.
   PubMed Web of Science ®Google Scholar
• Park YS, Ha Choi Y, Park CH, Kim KT. 2008. Nongenomic glucocorticoid effects on activity-dependent potentiation of catecholamine release in chromaffin cells. Endocrinology. 149:4921–4927.
   Google Scholar
• Rybakowski JK. 2008. BDNF gene: Functional Val66Met polymorphism in mood disorders and schizophrenia. Pharmacogenomics. 9:1589–1593.
   PubMed Web of Science ®Google Scholar
• Shalev I, Lerer E, Israel S, Uzefovsky F, Gritsenko I, Mankuta D, Ebstein RP, Kaitz M. 2009. BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions. Psychoneuroendocrinology. 34:382–388.
   PubMed Web of Science ®Google Scholar
• Slagter HA, Lutz A, Greischar LL, Francis AD, Nieuwenhuis S, Davis JM, Davidson RJ. 2007. Mental training affects distribution of limited brain resources. PLoS Biol. 5:e138.
   PubMed Web of Science ®Google Scholar
• Tunbridge EM, Bannerman DM, Sharp T, Harrison PJ. 2004. Catechol-O-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci. 24:5331–5335.
   PubMed Web of Science ®Google Scholar
• Vestergaard-Poulsen P, van Beek M, Skewes J, Bjarkam CR, Stubberup M, Bertelsen J, Roepstorff A. 2009. Long-term meditation is associated with increased gray matter density in the brain stem. Neuroreport. 20:170–174.
   PubMed Web of Science ®Google Scholar
• Waugh CE, Dearing KF, Joormann J, Gotlib IH. 2009. Association between the catechol-O-methyltransferase Val158Met polymorphism and self-perceived social acceptance in adolescent girls. J Child Adolesc Psychopharmacol. 19:395–401.
   Google Scholar
• Xiong GL, Doraiswamy PM. 2009. Does meditation enhance cognition and brain plasticity?. Ann N Y Acad Sci. 1172:63–69.
   PubMedGoogle Scholar
• Zou YF, Wang Y, Liu P, Feng XL, Wang BY, Zang TH, Yu X, Wei J, Liu ZC, Liu Y, Tao M, Li HC, Li KQ, Hu J, Li M, Zhang KR, Ye DQ, Xu XP. 2010. Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients. Neuropsychobiology. 61:71–78.
   PubMed Web of Science ®Google Scholar
• Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D. 2003. COMT Val158Met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science. 299:1240–1243.
   PubMed Web of Science ®Google Scholar